Cardia Bioplastics (ASX:CNN) Total Stockholders Equity : A$20.15 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Total Stockholders Equity?

Cardia Bioplastics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$20.15 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cardia Bioplastics's Book Value per Share for the quarter that ended in Dec. 2023 was A$N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cardia Bioplastics's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.07.

Cardia Bioplastics Total Stockholders Equity Historical Data

The historical data trend for Cardia Bioplastics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Total Stockholders Equity Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

10.00

11.38

29.22

26.67

23.13

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															28.98	26.67	24.08	23.13	20.15

Cardia Bioplastics (ASX:CNN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cardia Bioplastics's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(20.153	-	0)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cardia Bioplastics's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.585	+	0.815)	/	20.153
	=	0.07

Cardia Bioplastics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines